Beta blockers synthesis

Martinez Lagos, F., Carballeira, J.D., Bermudez, J.L. et al. (2004) Highly stereoselective reduction of haloketones using three new yeasts application to the synthesis of (S)-adrenergic beta-blockers related to propranolol. Tetrahedron Asymmetry, 15 (5), 763-770. 

H. S. Yang, W. M. Wu, N. Bodor, Soft Drugs. XX. Design, Synthesis and Evaluation of Ultra-Short Acting Beta-Blockers , Pharm. Res. 1995, 12, 329-336. 

Synthesis of a new molecular structure (new chemical entity or NCE) with possible biological significance. Discovery of a new pharmacologic action (e.g., the beta-blockers and the -antagonists). 

Scheme 9.4 Problems encountered during opening of typical epoxide intermediate (see also Section 9.4, Chemical Synthesis) when intended N-external ester substituents do not bear alpha-substituents [10]. A Normal, well-behaved reaction as typically deployed for beta-blockers wherein the N-alkyl group bears an alpha-substituent as most commonly represented by isopropylamine. B The over-alky-lation problem that occurs significantly when the N-alkyl group is not alpha-substituted. Also note that when n = 3 or 4, the first alkylation is instead followed immediately by an intramolecular ring-closure reaction to form the five- or six-membered lactam. These unwanted side products, although readily...

BETA-BLOCKERS NSAIDS - INDOMETACIN, PIROXICAM, POSSIBLY IBUPROFEN, NAPROXEN 1 hypotensive efficacy of beta-blockers. There does not seem to be this effect with other NSAIDs Additive toxic effects on kidney, and sodium and water, retention by NSAIDs. NSAIDs can raise BP by inhibiting renal synthesis of vasodilating prostaglandins. It is uncertain why this effect is specific to these NSAIDs Watch for 1 response to beta-blockers... 

The antihypertensive effect of beta-blockers can be impaired by the concurrent administration of some nonsteroidal anti-inflammatory drugs (NSAIDs), possibly because of inhibition of the synthesis of renal vasodilator prostaglandins. This interaction is probably common to all beta-blockers, but may not occur with aU NSAIDs for example, sulindac appears to affect blood pressure less than indometacin (405-407). 

Bufuralol (11) is a p-adrcnoccptor agent (beta-blocker), developed by Roche [8,9], As part of a continuing program on the synthesis of substrates and metabolites for Cytochrome P450 studies, we wished to prepare both optically active bufuralol and an important metabolite, the hydroxybufuralol (12). This brief account of our efforts illustrates the way in which classical resolution is giving way to asymmetric synthesis, whether mediated by synthetic chiral auxiliaries, conventional catalysts, or enzymes. 

More than a laboratory synthesis. Sharpless epoxidation has been adapted to the large-scale preparation of (+)-disparlure, a sex pheromone used to control gypsy moth infestations, and of (/ )-glycidol, an intermediate in the synthesis of cardiac drugs known as beta-blockers. 

The first papers on timolol came from C. E. Frosst Co. In the 1970s, Merck Sharp Dohme filed patent applications as weU for their synthesis. [ 127] Timolol is one of the few beta-blockers, which are marketed as pure enantiomers. Whereas in the first syntheses the racemic product was separated into its enantiomers with (+)-tartaric acid, later efforts were directed towards direct formation ofthe enantiomericaUypure drug from isoprop)didene-(D)-glyceraldehyde. 

Following is a two-step synthesis of the antihypertensive drug propranolol, a so-called beta blocker with vasodilating action (See Example 10.10)... 

Viswanathan, C. L. Tipnis, H. P. Synthesis and biological evaluation of a new series of potential beta blockers with dual pharmacological actions. Indian Drugs 1990, 27, 513-515. 

Weng X, Bao Z, Xing H, Zhang Z, Yang Q, Su B, Yang Y, Ren Q (2013) Synthesis and characterization of cellulose 3,5-dimethylphenylcarbamate silica hybrid spheres for enantioseparation of chiral beta-blockers. J Chromatogr A 1321 38-47... 

Pedragosa-Moreau, S., Morisseau, C., Baratti, ]., Zylber, ]., Archelas, A. and Furstoss, R. (1997) Microbiological transformations. 37. An enantioconvergent synthesis of the beta-blocker -Nifenalol using a combined chemoenzymatic approach. Tetrahedron, 53, 9707-9714. 

Some lipases and one esterase were used as enzymes for the reaction. The catalysis was performed in both n-hexane and SCCO2. The ester-racemate as substrate is soluble in hexane or SCCO2. The deprotonated acid should be soluble in the aqueous phase. Figure 7 shows the general reaction scheme for the enzymatic reaction. The class of 3-hydroxy esters represents useful chiral precursors for the synthesis of a wide variety of natural compounds as well as pharmaceutically active substances such as beta blockers. The solubility of HPAE (Fig. 8) in n-hexane was investigated since its solvating properties are similar to those of SCCO2 and allow easy estimation of the accessible substrate concentration in the reaction mixture under supercritical conditions. 

Beta-adrenoceptor blockers block the sympathetic system antagonising the effect on the lungs, resulting in bronchoconstriction. Non-steroidal anti-inflammatory drugs inhibit prostaglandin synthesis, which may lead to bronchoconstriction. 

Currently there is a trend toward the synthesis and large-scale production of a single active enantiomer in the pharmaceutical industry [61-63]. In addition, in some cases a racemic drug formulation may contain an enantiomer that will be more potent (pharmacologically active) than the other enantiomer(s). For example, carvedilol, a drug that interacts with adrenoceptors, has one chiral center yielding two enantiomers. The (-)-enantiomer is a potent beta-receptor blocker while the (-i-)-enantiomer is about 100-fold weaker at the beta-receptor. Ketamine is an intravenous anesthetic where the (+)-enantiomer is more potent and less toxic than the (-)-enantiomer. Furthermore, the possibility of in vivo chiral inversion—that is, prochiral chiral, chiral nonchiral, chiral diastereoisomer, and chiral chiral transformations—could create critical issues in the interpretation of the metabolism and pharmacokinetics of the drug. Therefore, selective analytical methods for separations of enantionmers and diastereomers, where applicable, are inherently important. 

---